Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischemic stroke

References

• de Fronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: A balanced overview. Diabetes Care 1992; 15: 318–368
   PubMed Web of Science ®Google Scholar
• Bonora E, Kiechi S, Willett J, et al. Insulin resistance as estimatedby homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: The Bruneck Study. Diabetes Care 2007; 30: 318–324
   PubMed Web of Science ®Google Scholar
• Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952–957
   PubMed Web of Science ®Google Scholar
• Suzuki M, Shinozaki K, Kanazawa A, et al. Insulin resistance as anindependent risk factor for carotid wall thickening. Hypertension 1996; 28: 593–598
   PubMed Web of Science ®Google Scholar
• Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose tolerance. Arterioscler Thromb Vase Biol 2003; 23: 295–301
   PubMed Web of Science ®Google Scholar
• Hedblad B, Nilsson P, Jonzon L, et al. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmi5 Sweden. Diabet Med 2000; 17: 299–307
   PubMed Web of Science ®Google Scholar
• Kernan WN, Inzucchi SE, Viscoli CM, et al. Insulin resistance andrisk for stroke. Neurology 2002; 59: 809–815
   PubMed Web of Science ®Google Scholar
• Longstreth W, Jr, Manolio TA, Arnold A, et al. Clinical correlatesof white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274–1282
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis 2006; 22: 83–90
   PubMed Web of Science ®Google Scholar
• Leeuw FE, Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9–14
   PubMed Web of Science ®Google Scholar
• Dufouil C, de Kersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: The EVA-MRI cohort. Neurology 2001; 56: 921–926
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28: 1932–1939
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population. The Rotterdam Scan Study. Stroke 2003; 34: 1126–1129
   PubMed Web of Science ®Google Scholar
• de Groot JC, de Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002; 52: 335–341
   PubMed Web of Science ®Google Scholar
• Pohjasvaara TI, Jokinen H, Ylikoski R, et al. White matter lesions are related to impaired instrumental activities of daily living poststroke. J Stroke Cerebrovasc Dis 2007; 16: 251–258
   PubMedGoogle Scholar
• Shimomura T, Anan F, Umeno Y, et al. Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Neurol 2008; 15: 289–294
   PubMed Web of Science ®Google Scholar
• Anan F, Masaki T, Iwao T, et al. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients. Curr Med Res Opin 2008; 24: 1561–1567
   PubMed Web of Science ®Google Scholar
• Special Report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III. Stroke 1990; 21: 637–676
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Uchiyama S, Maruyama S. Alterations of haemo-static markers in various subtypes and phases of stroke. Blood Coagul Fibrinolysis 1993; 4: 707–712
   PubMed Web of Science ®Google Scholar
• Dahl T, Kontny F, Slagsvold CE, et al. Lipoproteina, other lipoproteins and hemostatic profiles in patients with ischemic stroke: The relation to cardiogenic embolism. Cerebrovasc Dis 2000; 10: 110–117
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, et al. Homeostatic model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57–63
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglyce-mia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38: 387–395
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk J, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 1987; 8: 421–426
   Web of Science ®Google Scholar
• Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25: 2220–2226
   PubMed Web of Science ®Google Scholar
• van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–607
   PubMed Web of Science ®Google Scholar
• DeGraba TJ, Hallenbeck JM, Pettigrew KD, et al. Progression in acute stroke: Value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999; 30: 1208–1212
   PubMed Web of Science ®Google Scholar
• Sulter G, Steen C, de Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999; 30: 1538–1541
   PubMed Web of Science ®Google Scholar
• Park K, Yamada N, Toyonaka S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007; 69: 974–978
   PubMed Web of Science ®Google Scholar
• Namba A, Hamano H, Kitagawa Y, et al. Asymptomatic cerebral ischemic lesions on MRI in patients with first-ever stroke: Characteristic features and relation to risk factors in ischemic stroke. Jpn J Stroke 1997; 19: 389–396
   Google Scholar
• Fu JH, Lu CZ, Hong Z, et al. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 793–796
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Chaker H, Leaming R, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601–2610
   PubMed Web of Science ®Google Scholar
• Erdfis B, Miller AW, Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol 2002; 282: H2060—H2065
   PubMed Web of Science ®Google Scholar
• Hoth KF, Tate DF, Poppas A, et al. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007; 38: 308–312
   PubMed Web of Science ®Google Scholar
• Wada M, Nagasawa H, Kurita K, et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 2007; 255: 27–34
   PubMed Web of Science ®Google Scholar
• Burchfiel CM, Curb JD, Rodriguez BL, et al. Glucose intolerance and 22-year stroke incidence: The Honolulu Heart Program. Stroke 1994; 25: 951–957
   PubMed Web of Science ®Google Scholar